Here's the latest news from Santéand its portfolio companies
Santé
Biotech Investing At The Earliest Stages With Santé Ventures’ Omar Khalil
Santé
Biotech Venture Funding Roars Back
Portfolio
RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology
Portfolio
Surgical Safety Technologies Becomes Aimbient, Expanding Ambient AI Across the Procedural Environment
Portfolio
Endogenex Announces Full Enrollment of the ReCET Clinical Study
Portfolio
Reimagine Care and The Center for Cancer and Blood Disorders Redefine Support for Patients on Advanced Cancer Therapies
Portfolio
Endovascular Engineering Collects $80 Million in Funding
Portfolio
Sonire Therapeutics Completes Enrollment in SUNRISE-I Randomized Controlled Trial of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
Portfolio
Iterion Therapeutics Reports First Clinical Validation of Tegavivint as a Targeted Therapy for Wnt-Driven Advanced HCC in Oral Presentation at 2026 ASCO Annual Meeting
Portfolio
Reimagine Care: Interview With Chief Growth Officer John Elliott About The At-Home Cancer Care Platform
Portfolio
Accrete Health Partners Invests in REVELOHEALTH® to Strengthen Contract Performance and Reimbursement Accuracy
Portfolio
Sensorium Therapeutics to Present SNTX-2643 Mechanistic Data and Phase 1a Study Design at ASCP 2026
Portfolio
Apreo Health® Adds Independent Director and Strategic Investor to Advance Novel Airway Scaffold for Severe Emphysema
Portfolio
Personalized DNA Vaccine Shows Immune Activation and Survival Signals in Glioblastoma Trial
Portfolio
Iterion Therapeutics Announces Oral Presentation of Phase 1/2 Tegavivint Data in Advanced Hepatocellular Carcinoma at the 2026 ASCO Annual Meeting
Portfolio
Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development
